Full Press Release Details
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises TransMedics Group, Inc. (NASDAQ: TMDX) investors that the law firm has initiated an investigation on behalf of investors that lost money on their TransMedics stock. TransMedics investors are encouraged to contact the firm to discuss their legal rights.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On Monday, February 26, shares of TransMedics dropped over 9% following a report from Canaccord Genuity that highlighted "potential risk" to the company. This concern was triggered by a letter from Representative Paul Gosar accusing TransMedics of misappropriating corporate resources, among other allegations. Additionally, a report from the Washington Post detailed a federal investigation into organ transplant organizations, adding to the company's troubles. TransMedics is known for developing the Organ Care System, which has received FDA approval.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
Attorney Advertising